, Clover Health to raise $3.7 billion in SPAC IPO
Clover Health will merge with Social Capital Hedosophia lll, a SPAC, to go public to avoid unnecessary costs and delays.
, Herbalife Top Distributors May Face a Class Action Suit for Fraudulent Claims of Lavish Lifestyle
Multi level marketing models are intrinsically flawed as they benefit only the people at the top of the pyramid, but the aggressive marketing lures many and now Herbalife is facing a class action suit for the same tactics.
, FDA Authorizes Convalescent Plasma as Potential COVID-19 Treatment
According to the FDA, 70,000+ patients had so far been treated with convalescent plasma. The plasma is made using the blood of people who recovered from coronavirus infections.
, Takeda to sell drug subsidiary to Blackstone Group for $2.3 billion
Takeda Pharmaceutical Co. has agreed to sell its Japanese consumer healthcare business to US private equity firm The Blackstone Group for $2.3 billion.
, US signs agreement to pay Moderna $1.5 billion for 100 million doses of vaccine
The US government wants first access to the vaccine for its citizens. The payment includes delivery of 100 million doses and incentive payments for timely delivery of the product.
, Bausch health hives off Bausch + Lomb, news pushes stock prices up
Canada-headquartered Bausch Health Companies Inc plans to hive off its eye-care unit, Bausch + Lomb, into a separate publicly listed company. It acquired the …
, Biogen, Denali to partner for development of Parkinson’s disease Med
The partnership is bound to attract a lot of attention as Parkinson’s, a debilitating degenerative neuro disease has no known cure. A medicinal program will push both companies in positive territory revenue-wise.
, Kodak involved in SEC investigations of insider trading and breach of policy
The US Securities and Exchange Commission (SEC) is looking into Eastman Kodak Co.’s handling of information regarding a massive federal drug loan of $765 …
, From Photos to Pharma, Kodak is having a moment
Eastman Kodak that’s been failing to make a mark on the Wall Street is now having a moment. Kodak stock tripled after the company announced it is pivoting to become a pharmaceutical powerful.
, US Govt Signs $2 billion deal with Pfizer for Covid-19 vaccines
The U.S. government has signed an agreement worth $1.95 billion with Pfizer and BioNTEch to produce and deliver 100 million doses of their Covid-19 vaccines. It is the largest such deal between the government and companies racing to develop a coronavirus vaccine.
, MultiPlan and Churchill Merge for $11 Billion, Company will go public
Churchill Capital Corp III, a special purpose acquisition company (SPAC), and MultiPlan Inc, a healthcare company, have agreed to merge in a deal worth $11 billion. The combined company will be called MultiPlan and will go public.
, Allstate Acquires National General for $4 billion in an all-cash deal
Allstate, the US insurance company, has agreed to acquire National General Holding Corp for $4 billion in an all-cash deal. Allstate is a leader …
, Stanford researchers develop a new ultrafast insulin
Researchers at Stanford University are working on a fast-acting ultrafast insulin formulation that acts four-times faster than the present formulations available in the market. …
, New Quick, Easy Covid-19 Test Will Help In Population Screening
Experts fighting the Covid-19 pandemic emphasize testing as a way to combat the virus from spreading faster. There is a constant search for a …
, Under Armour’s UA Sportsmask aimed at athletes sells out in an hour of launch
Under Armour launched a new facemask specifically aimed for sportspeople, making it easier to breathe while exercising. The UA Sportsmask was sold out online within …
, Fitbit Developed ‘Fitbit Flow,’ A Low-Cost Ventilator To Help COVID-19 Patients
Fitbit recently announced a significant development of a high-quality, low-cost, easy-to-use emergency ventilator, named Fitbit Flow. In response to the COVID-19 pandemic, the company created …
, Moderna Racing towards Second Phase of COVID Vaccine Trials
The COVID-19 coronavirus pandemic has affected 6 million people worldwide since it started spreading nearly six months ago. There have been 376,000 reported deaths …
, AstraZeneca to Begin Supplying COVID-19 Vaccine in September
The University of Oxford and AstraZeneca Plc have begun recruiting over 10,000 subjects for advanced human trials of experimental COVID-19 vaccine. If everything goes …
, Remdesivir Shortens Recovery Period of Covid-19 Patients, Still Under Experiment
Remdesivir, an experimental drug, is being tested on patients to determine its efficacy against the COVID-19 in people suffering from mild to severe respiratory …
, ATMOBLUE: Smart Mask That Delivers 99.5% Filtered Air
Face masks have become the most ubiquitous item of functionality in today’s world. Earlier, only health care workers and hygiene conscious and pollution weary …
, Surge In Demand for Marijuana during Lockdown Favors Pot Stocks
Pot stocks are seeing unprecedented gains after suffering some initial lows in the coronavirus crisis. As the coronavirus spread, the United States government and …
